Cetera Advisors LLC buys 1,455 shares of STERIS plc (NYSE:STE)

VaselineAugust 10, 2024

0 4 minutes read

Cetera Advisors LLC boosted its holdings in shares of STERIS plc (NYSE:STE – Free Report) by 53.7% in the first quarter, Holdings Channel.com reports. The fund owned 4,164 shares of the medical equipment provider’s stock after acquiring an additional 1,455 shares during the period. Cetera Advisors LLC’s holdings in STERIS were worth $936,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have recently modified their holdings of the company. International Assets Investment Management LLC bought a new stake in shares of STERIS in the fourth quarter valued at approximately $2,223,000. Cerity Partners LLC increased its position in shares of STERIS by 5,199.4% in the 4th quarter. Cerity Partners LLC now owns 65,925 shares of the medical equipment provider’s stock valued at $14,494,000 after purchasing an additional 64,681 shares. shares in the last quarter. NewEdge Wealth LLC purchased a new position in shares of STERIS in the fourth quarter valued at about $244,000. Louisiana State Employees Retirement System bought a new stake in STERIS during the fourth quarter valued at approximately $1,319,000. Finally, Strs Ohio boosted its holdings in STERIS by 16.4% in the fourth quarter. Strs Ohio now owns 60,496 shares of the medical equipment provider’s stock valued at $13,300,000 after buying an additional 8,518 shares in the last quarter. 94.69% of shares are held by hedge funds and other institutional investors.

Analyst upgrades and downgrades

STE has been the subject of several analyst reports. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Thursday. Stephens reiterated an “overweight” rating and issued a $260.00 target price on shares of STERIS in a research note on Wednesday. JMP Securities restated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research report on Wednesday. StockNews.com lowered STERIS from a “buy” rating to a “hold” rating in a research note on Monday, August 5th. Finally, Piper Sandler restated a “neutral” rating and set a $225.00 price objective (up from $220.00) on shares of STERIS in a report on Friday, May 10th. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, STERIS has an average rating of “Hold” and a consensus price target of $243.60.

Want more great investment ideas?

See the latest stock report on STE

STERIS trading down 1.5%

Shares of STE stock traded up $3.70 during trading hours on Friday, reaching $235.98. 427,048 shares of the stock were exchanged, compared to its average volume of 488,756. The firm has a market cap of $23.33 billion, a price-to-earnings ratio of 61.77 and a beta of 0.83. STERIS plc has a 12-month low of $195.47 and a 12-month high of $243.37. The company’s 50-day moving average price is $225.17 and its 200-day moving average price is $222.88. The company has a current ratio of 3.08, a quick ratio of 2.36, and a debt-to-equity ratio of 0.49.

STERIS (NYSE:STE – Get Your Free Report ) last announced its earnings results on Tuesday, August 6th. The medical equipment provider reported $2.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.98 by $0.16. STERIS had a return on equity of 13.89% and a net margin of 7.36%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. In the same quarter last year, the company earned $2.00 per share. The company’s revenue for the quarter was down 0.4% compared to the same quarter last year. As a group, equities analysts anticipate that STERIS plc will post 9.16 earnings per share for the current year.

STERIS increases dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 20th. Stockholders of record on Thursday, September 5th will be given a dividend of $0.57 per share. This represents an annualized dividend of $2.28 and a dividend yield of 0.97%. This is an increase from STERIS’s previous quarterly dividend of $0.52. The ex-dividend date is Thursday, September 5. STERIS’s dividend payout ratio (DPR) is 59.69%.

Indoor activity

In other STERIS news, Director Jacqueline B. Kosecoff sold 4,584 shares of the firm’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $231.53, for a total value of $1,061,333.52. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, Director Jacqueline B. Kosecoff sold 4,584 shares of the firm’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $231.53, for a total transaction of $1,061,333.52. The sale was disclosed in a filing with the SEC, which is accessible via this link. Also, VP Renato Tamaro sold 1,154 shares of the stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $231.64, for a total transaction of $267,312.56. Following the transaction, the vice president now owns 6,677 shares in the company, valued at $1,546,660.28. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,762 shares of company stock worth $1,798,477. 1.14% of shares are currently owned by company insiders.

STERIS Company Profile

(Free report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment offers cleaning chemicals and sterility products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers and other capital parts for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lighting and connectivity solutions, as well as equipment management services.